Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GW6K
|
||||
Former ID |
DNCL003084
|
||||
Drug Name |
ADX N05
|
||||
Indication | Mood disorder [ICD10:F30-F39] | Phase 3 | [1] | ||
Excessive daytime sleepiness [ICD9: 291.82, 292.85, 307.43-307.44, 327.1, 780.53-780.54; ICD10:F51.1, G47.1] | Phase 2 | [1] | |||
Company |
Aerial BioPharma
|
||||
Target and Pathway | |||||
Target(s) | Sigma(1)-type opioid receptor | Target Info | Modulator | [2] | |
WikiPathways | miR-targeted genes in squamous cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030225) | ||||
REF 2 | Clinical pipeline report, company report or official report of SK BioPhamaceuticals. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.